Pharming Group N.V. PHAR
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 158.28M | 170.18M | 179.10M | 166.17M | 126.01M |
| Total Receivables | 56.98M | 60.03M | 48.44M | 43.61M | 53.33M |
| Inventory | 65.43M | 64.58M | 64.90M | 67.14M | 63.72M |
| Prepaid Expenses | -- | -- | 6.26M | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 725.00K | 762.00K | 690.00K | 2.73M |
| Total Current Assets | 280.69M | 295.51M | 299.47M | 277.60M | 245.78M |
|
|
|||||
| Total Current Assets | 280.69M | 295.51M | 299.47M | 277.60M | 245.78M |
| Net Property, Plant & Equipment | 20.48M | 23.10M | 23.97M | 24.99M | 24.57M |
| Long-term Investments | -- | -- | 3.32M | -- | -- |
| Goodwill | -- | -- | 3.32M | -- | -- |
| Total Other Intangibles | 128.08M | 130.99M | 132.22M | 134.93M | 135.90M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 30.16M | 31.66M | 32.34M | 29.59M | 33.32M |
| Total Assets | 467.98M | 489.37M | 499.96M | 473.79M | 446.26M |
|
|
|||||
| Total Accounts Payable | 82.32M | 103.53M | 8.55M | 78.22M | 78.38M |
| Total Accrued Expenses | -- | -- | 91.31M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.05M | 8.15M | 8.71M | 9.69M | 9.56M |
| Total Finance Division Other Current Liabilities | 1.88M | 675.00K | 7.23M | -1.00K | -- |
| Total Other Current Liabilities | 1.88M | 675.00K | 7.23M | -1.00K | -- |
| Total Current Liabilities | 93.25M | 112.35M | 115.79M | 87.91M | 87.94M |
|
|
|||||
| Total Current Liabilities | 93.25M | 112.35M | 115.79M | 87.91M | 87.94M |
| Long-Term Debt | 92.40M | 93.39M | 92.72M | 93.14M | 91.27M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 11.85M | 14.67M | 14.35M | 28.09M | 27.50M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -1.00K | -- | -1.00K | -- |
| Total Liabilities | 197.49M | 220.41M | 222.86M | 209.14M | 206.71M |
|
|
|||||
| Common Stock & APIC | 528.39M | 526.67M | 521.27M | 515.67M | 499.67M |
| Retained Earnings | -271.36M | -281.46M | -258.00M | -276.88M | -286.03M |
| Treasury Stock & Other | 13.46M | 23.75M | 13.84M | 25.85M | 25.91M |
| Total Common Equity | 270.49M | 268.96M | 277.10M | 264.64M | 239.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 270.49M | 268.96M | 277.10M | 264.64M | 239.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 270.49M | 268.96M | 277.10M | 264.64M | 239.55M |
|
|
|||||